15 - 17 February, 2012, London, UK
Register by January 20 2012* and receive up to £200off!
Download the Info Pack
Access our Download Centre
Become a Pharma IQ Member and receive our weekly newsletter!
Connect to a global Pharma IQ social network
Learn more about sponsor & exhibit opportunities
Mark Your Calendar
Tell a Colleague
Laszlo Urban, Preclinical Safety ProfilingNIBR, Cambridge, Ma. presents: How To Mitigate Cardiac Toxicity During Lead Selection And Lead Optimization?
Paul Hastwell, Safety Assessment, GSK
Frank W Bonner, Stem Cell for Safer Medicines (SC4SM) presents: Exploring the Potential of Stem Cell Assays in Predictive Toxicology Testing
James A. Dykens, Investigative Toxicity Drug Safety Research & Development Sandwich, UK
Glyn Stacey, NIBSC-HPA presents: UK Stem Cell Bank: Supporting the Development of Stem Cell Models for Safety Testing.
M.B. Friedman, PhD, DABT Director of Toxicology
David R Jones, Expert Scientific Assessor (Pharmacotoxicologist), Licensing Division, Medicines and Healthcare products Regulatory Agency (MHRA), UK presents: Predictive Toxicology A Regulatory View
Vasily Dobrovolsky, Division of Genetic and Reproductive Toxicology, National Center for Toxicological Reasearch USFDA(DGRT/NCTR/FDA)
The cost of discovering and developing a drug now is currently tipped at approximately $900 million, resulting in continually growing pressure to avoid late stage drug attrition and its associated costs.
One of the most useful tools in the pharmaceutical R&D metaphorical ‘toolbox’ is predictive toxicology. By accurately predicting the toxicological effect or even the efficacy of a drug or a specific compound, steps can be taken to either improve the drug or identify the root cause of the issue, thereby preventing the significantly more costly discovery of these effects while in clinical trials.
It is clear that this pressure translates into a need to take these strategic decisions as early in drug discovery as possible, and to ensure the accuracy of predictions by using the latest and greatest models, assays and technologies available.
In light of this, the 4th Annual Predictive Toxicology Summit 2012 will explore the most cutting edge techniques, technologies and strategies to enable you to confidently predict drug toxicity. Also, for the first time ever, your pass this year will also grant you entry into the co-located inaugural Stem Cell Summit 2012, covering novel and innovative stem cell therapies, regenerative medicine and of course the practical application of stem cell models in toxicological and efficacy screening.
See you in London!
“Overall very valuable, learning about new technology & forming partnerships to move the industry forward”
“An excellent, informative conference as a refresher for current standing in predictive tox”
“Highly valuable and useful”
[ Register Now ]
Questions? Contact us on 0800 652 2363 or +44 (0) 20 7368 9300 or email firstname.lastname@example.org now!